Traditionally, breast cancer prognosis and classification have relied on analysis of tumor morphology and expression of three markers, i.e., estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor2 (HER2). The gene discussed is PGR; the disease is neoplasm.